Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Oxymorphone extended release

Gabrail NY, Dvergsten C, Ahdieh H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain a randomized controlled study. CurrMed Res Opin. 2004 20 911-918. [Pg.25]

Kivitz A, Ma C, Ahdieh H. Oxymorphone extended release improves pain and quality of life in patients with osteoarthritis Results of a doseranging study. Arthritis Rheum 2003 48 S485 (abstract). [Pg.1703]

OpanaER(R) (Oxymorphone extended-release capsules, Endo Pharmaceuticals Incorporated, Chadds Ford, Pennsylvania). Full prescribing information,... [Pg.81]

Figure 25 Pain Intensity as assessed with visual analog scale scores for patients with chronic low back pain during administration of oxymorphone extended-release (ER) or placebo. Screening = visit before enrollment, day 0 = baseline before randomization P, 0.001 versus placebo. With permission from Peniston JH and Gould E Oxymorphone extended-release tablets for control of chronic low back pain. Oin Therapeutics 200931347-359. Figure 25 Pain Intensity as assessed with visual analog scale scores for patients with chronic low back pain during administration of oxymorphone extended-release (ER) or placebo. Screening = visit before enrollment, day 0 = baseline before randomization P, 0.001 versus placebo. With permission from Peniston JH and Gould E Oxymorphone extended-release tablets for control of chronic low back pain. Oin Therapeutics 200931347-359.
Adams M, Pieniazek HJ, Gammaitoni AR, Ahdieh H. Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways. / Clin Pharmacol 2005 45 337-345. [Pg.127]

Sustained-release compounds usually offer better pain control throughout the day, and are used when simple narcotics are ineffective. A recent randomized double-blind placebo-controlled study showed that extended-release oxymorphone (40 to 50 mg twice daily) was superior to placebo in reducing pain and improving both function and quality of hfe. ... [Pg.1699]

Hydromorphone is more potent, has better oral absorption characteristics, and is more soluble than morphine, but its overall pharmacologic profile parallels that of morphine. A sustained-release hydromorphone product has recently become available. Oxymorphone can be administered rectally and by injection. Although it is more potent than morphine, it offers no real pharmacologic advantages. Levor-phanol has an extended half-life, bnt its overall therapeutic effects are similar to those of morphine. [Pg.1095]

See other pages where Oxymorphone extended release is mentioned: [Pg.123]    [Pg.123]    [Pg.125]    [Pg.123]    [Pg.123]    [Pg.125]    [Pg.71]    [Pg.124]    [Pg.79]   
See also in sourсe #XX -- [ Pg.123 , Pg.124 , Pg.125 , Pg.126 ]



SEARCH



Oxymorphone

Oxymorphones

© 2024 chempedia.info